Florida's HIV medication cutoff refers to the state's decision to drastically reduce eligibility for the AIDS Drug Assistance Program (ADAP), affecting an estimated 10,000 to 16,000 residents who rely on this critical support for accessing their medications. This measure has sparked outrage among health advocates and the community, as it threatens to undermine public health and the well-being of those living with HIV/AIDS in Florida, which already has one of the highest rates of new diagnoses in the country. The new eligibility criteria will lower the income threshold from 400% to 130% of the federal poverty level, effective March 1, 2026. This change is justified by state officials citing rising healthcare costs and a lack of federal funding, yet critics argue that it will only exacerbate existing issues, pushing many individuals into a precarious situation where they might lose access to life-saving treatment altogether. Maintaining HIV medication assistance is crucial not only for individual health but also for public health at large. Ensuring that those living with HIV have access to their medications helps prevent the spread of the virus and reduces long-term healthcare costs by improving health outcomes. Furthermore, support for vulnerable communities—including low-income individuals and marginalized groups—ensures that everyone has equitable access to necessary healthcare services, thus fostering a healthier society overall. However, the limitations of these cuts are clear, as many affected individuals face increased health risks without viable alternative assistance options. The abrupt nature of these changes leaves thousands scrambling for solutions, potentially leading to a resurgence of HIV infections and additional strain on the healthcare system in Florida. Advocacy groups are calling for transparency and a reversal of these cuts to safeguard the health of the community.